Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVieSeeking Alpha • 02/26/26
This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing IncomeThe Motley Fool • 02/24/26
AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United StatesPRNewsWire • 02/23/26
Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent CliffsZacks Investment Research • 02/23/26
Will Immunology Drugs Continue to Drive AbbVie's Top Line in 2026?Zacks Investment Research • 02/20/26
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)PRNewsWire • 02/20/26
The Zacks Analyst Blog AbbVie, RTX, International Business Machines, EVI Industries, and Rocky Mountain Chocolate FactoryZacks Investment Research • 02/18/26
AbbVie Inc. (ABBV) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium TranscriptSeeking Alpha • 02/13/26